This bifunctional PEG linker enables the conjugation of two diethylstilbestrol (DES) ligands, creating potent and selective estrogen receptor (ER) antagonists for breast cancer research. It is used in the development of novel endocrine therapies, with applications in both in vitro receptor binding assays and in vivo pharmacological studies.
